Can Fite Biopharma Ltd
TASE:CANF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Can Fite Biopharma Ltd
TASE:CANF
|
IL |
|
Vidrala SA
F:VIR
|
ES |
|
Plazza AG
F:2PZ
|
CH |
|
H
|
Huntington Bancshares Inc
XMUN:HU3
|
US |
|
A
|
Axos Financial Inc
SWB:BB4
|
US |
|
A
|
Alamo Group Inc
F:AL3
|
US |
|
F
|
Fast Retailing Co Ltd
SWB:FR7
|
JP |
|
A
|
American Eagle Outfitters Inc
SWB:AFG
|
US |
|
U
|
Unum Group
DUS:UUM
|
US |
|
Uber Technologies Inc
NYSE:UBER
|
US |
|
Burckhardt Compression Holding AG
SIX:BCHN
|
CH |
|
Samudera Shipping Line Ltd
SGX:S56
|
SG |
|
B
|
BacKan Mineral Joint Stock Corp
VN:BKC
|
VN |
|
B
|
Bandai Namco Holdings Inc
XMUN:N9B
|
JP |
Bankruptcy Probability
Can Fite Biopharma Ltd's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Can Fite Biopharma Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| IL |
C
|
Can Fite Biopharma Ltd
TASE:CANF
|
14m ILS |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
459.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
220.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
183B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
128.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
76B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
75.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
84B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
58.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
51B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
44.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Can Fite Biopharma Ltd's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Can Fite Biopharma Ltd has no debt.
You can find a full breakdown on its Balance Sheet.